-
1
-
-
33644826473
-
Roots and stems: stem cells in cancer
-
10.1038/nm1379, 16520777
-
Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006, 12:296-300. 10.1038/nm1379, 16520777.
-
(2006)
Nat Med
, vol.12
, pp. 296-300
-
-
Polyak, K.1
Hahn, W.C.2
-
2
-
-
33644560281
-
Cancer stem cells: an old idea - a paradigm shift
-
discussion 1895-1886, 10.1158/0008-5472.CAN-05-3153, 16488983
-
Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006, 66:1883-1890. discussion 1895-1886, 10.1158/0008-5472.CAN-05-3153, 16488983.
-
(2006)
Cancer Res
, vol.66
, pp. 1883-1890
-
-
Wicha, M.S.1
Liu, S.2
Dontu, G.3
-
3
-
-
77956610796
-
Targeting breast cancer stem cells
-
10.1016/j.molonc.2010.06.005, 3023958, 20599450
-
McDermott SP, Wicha MS. Targeting breast cancer stem cells. Mol Oncol 2010, 4:404-419. 10.1016/j.molonc.2010.06.005, 3023958, 20599450.
-
(2010)
Mol Oncol
, vol.4
, pp. 404-419
-
-
McDermott, S.P.1
Wicha, M.S.2
-
4
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
10.1073/pnas.0530291100, 153034, 12629218
-
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
5
-
-
35848955428
-
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
-
10.1016/j.stem.2007.08.014, 2423808, 18371393
-
Ginestier C, Hur MH, Charafe-Jauff ret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567. 10.1016/j.stem.2007.08.014, 2423808, 18371393.
-
(2007)
Cell Stem Cell
, vol.1
, pp. 555-567
-
-
Ginestier, C.1
Hur, M.H.2
Charafe-Jauffret, E.3
Monville, F.4
Dutcher, J.5
Brown, M.6
Jacquemier, J.7
Viens, P.8
Kleer, C.G.9
Liu, S.10
Schott, A.11
Hayes, D.12
Birnbaum, D.13
Wicha, M.S.14
Dontu, G.15
-
6
-
-
79959213451
-
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers
-
Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA. Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers. Breast Cancer Res Treat 2010, 128:45-55.
-
(2010)
Breast Cancer Res Treat
, vol.128
, pp. 45-55
-
-
Kabos, P.1
Haughian, J.M.2
Wang, X.3
Dye, W.W.4
Finlayson, C.5
Elias, A.6
Horwitz, K.B.7
Sartorius, C.A.8
-
7
-
-
77953163539
-
CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer
-
10.1158/0008-5472.CAN-09-3619, 20484027
-
Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, Vonderhaar BK. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Res 2010, 70:4624-4633. 10.1158/0008-5472.CAN-09-3619, 20484027.
-
(2010)
Cancer Res
, vol.70
, pp. 4624-4633
-
-
Meyer, M.J.1
Fleming, J.M.2
Lin, A.F.3
Hussnain, S.A.4
Ginsburg, E.5
Vonderhaar, B.K.6
-
8
-
-
42549142322
-
Brca1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics
-
10.1186/bcr1855, 2374965, 18241344
-
Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24-and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008, 10:R10. 10.1186/bcr1855, 2374965, 18241344.
-
(2008)
Breast Cancer Res
, vol.10
-
-
Wright, M.H.1
Calcagno, A.M.2
Salcido, C.D.3
Carlson, M.D.4
Ambudkar, S.V.5
Varticovski, L.6
-
9
-
-
0037948854
-
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells
-
10.1101/gad.1061803, 196056, 12756227
-
Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270. 10.1101/gad.1061803, 196056, 12756227.
-
(2003)
Genes Dev
, vol.17
, pp. 1253-1270
-
-
Dontu, G.1
Abdallah, W.M.2
Foley, J.M.3
Jackson, K.W.4
Clarke, M.F.5
Kawamura, M.J.6
Wicha, M.S.7
-
10
-
-
21344454219
-
Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties
-
10.1158/0008-5472.CAN-05-0626, 15994920
-
Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511. 10.1158/0008-5472.CAN-05-0626, 15994920.
-
(2005)
Cancer Res
, vol.65
, pp. 5506-5511
-
-
Ponti, D.1
Costa, A.2
Zaffaroni, N.3
Pratesi, G.4
Petrangolini, G.5
Coradini, D.6
Pilotti, S.7
Pierotti, M.A.8
Daidone, M.G.9
-
11
-
-
44049100934
-
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
-
10.1093/jnci/djn123, 18445819
-
Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 2008, 100:672-679. 10.1093/jnci/djn123, 18445819.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 672-679
-
-
Li, X.1
Lewis, M.T.2
Huang, J.3
Gutierrez, C.4
Osborne, C.K.5
Wu, M.F.6
Hilsenbeck, S.G.7
Pavlick, A.8
Zhang, X.9
Chamness, G.C.10
Wong, H.11
Rosen, J.12
Chang, J.C.13
-
12
-
-
64749093574
-
Association of reactive oxygen species levels and radioresistance in cancer stem cells
-
10.1038/nature07733, 2778612, 19194462
-
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, Joshua B, Kaplan MJ, Wapnir I, Dirbas FM, Somlo G, Garberoglio C, Paz B, Shen J, Lau SK, Quake SR, Brown JM, Weissman IL, Clarke MF. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009, 458:780-783. 10.1038/nature07733, 2778612, 19194462.
-
(2009)
Nature
, vol.458
, pp. 780-783
-
-
Diehn, M.1
Cho, R.W.2
Lobo, N.A.3
Kalisky, T.4
Dorie, M.J.5
Kulp, A.N.6
Qian, D.7
Lam, J.S.8
Ailles, L.E.9
Wong, M.10
Joshua, B.11
Kaplan, M.J.12
Wapnir, I.13
Dirbas, F.M.14
Somlo, G.15
Garberoglio, C.16
Paz, B.17
Shen, J.18
Lau, S.K.19
Quake, S.R.20
Brown, J.M.21
Weissman, I.L.22
Clarke, M.F.23
more..
-
13
-
-
0034080318
-
The biology of chemokines and their receptors
-
10.1146/annurev.immunol.18.1.217, 10837058
-
Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242. 10.1146/annurev.immunol.18.1.217, 10837058.
-
(2000)
Annu Rev Immunol
, vol.18
, pp. 217-242
-
-
Rossi, D.1
Zlotnik, A.2
-
14
-
-
0025139959
-
Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily
-
Modi WS, Dean M, Seuanez HN, Mukaida N, Matsushima K, O'Brien SJ. Monocyte-derived neutrophil chemotactic factor (MDNCF/IL-8) resides in a gene cluster along with several other members of the platelet factor 4 gene superfamily. Hum Genet 1990, 84:185-187.
-
(1990)
Hum Genet
, vol.84
, pp. 185-187
-
-
Modi, W.S.1
Dean, M.2
Seuanez, H.N.3
Mukaida, N.4
Matsushima, K.5
O'Brien, S.J.6
-
15
-
-
0023554062
-
Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes
-
10.1016/0006-291X(87)90432-3, 3322281
-
Walz A, Peveri P, Aschauer H, Baggiolini M. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Biophys Res Commun 1987, 149:755-761. 10.1016/0006-291X(87)90432-3, 3322281.
-
(1987)
Biochem Biophys Res Commun
, vol.149
, pp. 755-761
-
-
Walz, A.1
Peveri, P.2
Aschauer, H.3
Baggiolini, M.4
-
16
-
-
0023632231
-
Purification and partial biochemical characterization of a human monocyte-derived, neutrophilactivating peptide that lacks interleukin 1 activity
-
Schroder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophilactivating peptide that lacks interleukin 1 activity. J Immunol 1987, 139:3474-3483.
-
(1987)
J Immunol
, vol.139
, pp. 3474-3483
-
-
Schroder, J.M.1
Mrowietz, U.2
Morita, E.3
Christophers, E.4
-
17
-
-
0023505508
-
Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines
-
10.1073/pnas.84.24.9233, 299727, 3480540
-
Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987, 84:9233-9237. 10.1073/pnas.84.24.9233, 299727, 3480540.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 9233-9237
-
-
Yoshimura, T.1
Matsushima, K.2
Tanaka, S.3
Robinson, E.A.4
Appella, E.5
Oppenheim, J.J.6
Leonard, E.J.7
-
18
-
-
0025264320
-
IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/ IL-8-related neutrophil chemotactic proteins in human dermal fi broblasts
-
Schroder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E. IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/ IL-8-related neutrophil chemotactic proteins in human dermal fi broblasts. J Immunol 1990, 144:2223-2232.
-
(1990)
J Immunol
, vol.144
, pp. 2223-2232
-
-
Schroder, J.M.1
Sticherling, M.2
Henneicke, H.H.3
Preissner, W.C.4
Christophers, E.5
-
19
-
-
0023881303
-
Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP)
-
10.1016/S0006-291X(88)80364-4, 3279957
-
Gregory H, Young J, Schroder JM, Mrowietz U, Christophers E. Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP). Biochem Biophys Res Commun 1988, 151:883-890. 10.1016/S0006-291X(88)80364-4, 3279957.
-
(1988)
Biochem Biophys Res Commun
, vol.151
, pp. 883-890
-
-
Gregory, H.1
Young, J.2
Schroder, J.M.3
Mrowietz, U.4
Christophers, E.5
-
20
-
-
0025974730
-
Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8
-
10.1084/jem.173.3.771, 2118810, 1997655
-
Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. J Exp Med 1991, 173:771-774. 10.1084/jem.173.3.771, 2118810, 1997655.
-
(1991)
J Exp Med
, vol.173
, pp. 771-774
-
-
Bazzoni, F.1
Cassatella, M.A.2
Rossi, F.3
Ceska, M.4
Dewald, B.5
Baggiolini, M.6
-
21
-
-
0024845454
-
Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions
-
10.1126/science.2688092, 2688092
-
Gimbrone MA, Obin MS, Brock AF, Luis EA, Hass PE, Hebert CA, Yip YK, Leung DW, Lowe DG, Kohr WJ, Darbonne WC, Bechtol KB, Baker JB. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 1989, 246:1601-1603. 10.1126/science.2688092, 2688092.
-
(1989)
Science
, vol.246
, pp. 1601-1603
-
-
Gimbrone, M.A.1
Obin, M.S.2
Brock, A.F.3
Luis, E.A.4
Hass, P.E.5
Hebert, C.A.6
Yip, Y.K.7
Leung, D.W.8
Lowe, D.G.9
Kohr, W.J.10
Darbonne, W.C.11
Bechtol, K.B.12
Baker, J.B.13
-
22
-
-
0025278534
-
Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells
-
1877641, 2183623
-
Elner VM, Strieter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 1990, 136:745-750. 1877641, 2183623.
-
(1990)
Am J Pathol
, vol.136
, pp. 745-750
-
-
Elner, V.M.1
Strieter, R.M.2
Elner, S.G.3
Baggiolini, M.4
Lindley, I.5
Kunkel, S.L.6
-
23
-
-
0025688896
-
Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung
-
10.1172/JCI114928, 329830, 2254454
-
Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, Westwick J, Strieter RM. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. J Clin Invest 1990, 86:1945-1953. 10.1172/JCI114928, 329830, 2254454.
-
(1990)
J Clin Invest
, vol.86
, pp. 1945-1953
-
-
Standiford, T.J.1
Kunkel, S.L.2
Basha, M.A.3
Chensue, S.W.4
Lynch, J.P.5
Toews, G.B.6
Westwick, J.7
Strieter, R.M.8
-
24
-
-
0031984834
-
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas
-
1858127, 9422527
-
Kitadai Y, Haruma K, Sumii K, Yamamoto S, Ue T, Yokozaki H, Yasui W, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol 1998, 152:93-100. 1858127, 9422527.
-
(1998)
Am J Pathol
, vol.152
, pp. 93-100
-
-
Kitadai, Y.1
Haruma, K.2
Sumii, K.3
Yamamoto, S.4
Ue, T.5
Yokozaki, H.6
Yasui, W.7
Ohmoto, Y.8
Kajiyama, G.9
Fidler, I.J.10
Tahara, E.11
-
25
-
-
0034629335
-
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells
-
10.1074/jbc.275.10.6868, 10702246
-
Venkatakrishnan G, Salgia R, Groopman JE. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 2000, 275:6868-6875. 10.1074/jbc.275.10.6868, 10702246.
-
(2000)
J Biol Chem
, vol.275
, pp. 6868-6875
-
-
Venkatakrishnan, G.1
Salgia, R.2
Groopman, J.E.3
-
26
-
-
0034655203
-
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer
-
Inoue K, Slaton JW, Kim SJ, Perrotte P, Eve BY, Bar-Eli M, Radinsky R, Dinney CP. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res 2000, 60:2290-2299.
-
(2000)
Cancer Res
, vol.60
, pp. 2290-2299
-
-
Inoue, K.1
Slaton, J.W.2
Kim, S.J.3
Perrotte, P.4
Eve, B.Y.5
Bar-Eli, M.6
Radinsky, R.7
Dinney, C.P.8
-
27
-
-
0037448628
-
IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells
-
10.1038/sj.onc.1206113, 2034407, 12527894
-
Freund A, Chauveau C, Brouillet J-P, Lucas A, Lacroix M, Licznar A, Vignon F, Lazennec G. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 2003, 22:256-265. 10.1038/sj.onc.1206113, 2034407, 12527894.
-
(2003)
Oncogene
, vol.22
, pp. 256-265
-
-
Freund, A.1
Chauveau, C.2
Brouillet, J.-P.3
Lucas, A.4
Lacroix, M.5
Licznar, A.6
Vignon, F.7
Lazennec, G.8
-
28
-
-
0027097806
-
Interleukin-8 as a macrophage-derived mediator of angiogenesis
-
10.1126/science.1281554, 1281554
-
Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801. 10.1126/science.1281554, 1281554.
-
(1992)
Science
, vol.258
, pp. 1798-1801
-
-
Koch, A.E.1
Polverini, P.J.2
Kunkel, S.L.3
Harlow, L.A.4
DiPietro, L.A.5
Elner, V.M.6
Elner, S.G.7
Strieter, R.M.8
-
29
-
-
20244390429
-
The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
-
10.1074/jbc.270.45.27348, 7592998
-
Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, Chan S, Roczniak S, Shanafelt AB. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995, 270:27348-27357. 10.1074/jbc.270.45.27348, 7592998.
-
(1995)
J Biol Chem
, vol.270
, pp. 27348-27357
-
-
Strieter, R.M.1
Polverini, P.J.2
Kunkel, S.L.3
Arenberg, D.A.4
Burdick, M.D.5
Kasper, J.6
Dzuiba, J.7
Van Damme, J.8
Walz, A.9
Marriott, D.10
Chan, S.11
Roczniak, S.12
Shanafelt, A.B.13
-
30
-
-
0026095795
-
Structure and functional expression of a human interleukin-8 receptor
-
10.1126/science.1840701, 1840701
-
Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278-1280. 10.1126/science.1840701, 1840701.
-
(1991)
Science
, vol.253
, pp. 1278-1280
-
-
Holmes, W.E.1
Lee, J.2
Kuang, W.J.3
Rice, G.C.4
Wood, W.I.5
-
31
-
-
0026018108
-
Cloning of complementary DNA encoding a functional human interleukin-8 receptor
-
10.1126/science.1891716, 1891716
-
Murphy PM, Tiff any HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991, 253:1280-1283. 10.1126/science.1891716, 1891716.
-
(1991)
Science
, vol.253
, pp. 1280-1283
-
-
Murphy, P.M.1
Tiffany, H.L.2
-
32
-
-
0027270778
-
Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35
-
10.1159/000133541, 8500355
-
Lloyd A, Modi W, Sprenger H, Cevario S, Oppenheim J, Kelvin D. Assignment of genes for interleukin-8 receptors (IL8R) A and B to human chromosome band 2q35. Cytogenet Cell Genet 1993, 63:238-240. 10.1159/000133541, 8500355.
-
(1993)
Cytogenet Cell Genet
, vol.63
, pp. 238-240
-
-
Lloyd, A.1
Modi, W.2
Sprenger, H.3
Cevario, S.4
Oppenheim, J.5
Kelvin, D.6
-
33
-
-
0028124275
-
Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene
-
Sprenger H, Lloyd AR, Meyer RG, Johnston JA, Kelvin DJ. Genomic structure, characterization, and identification of the promoter of the human IL-8 receptor A gene. J Immunol 1994, 153:2524-2532.
-
(1994)
J Immunol
, vol.153
, pp. 2524-2532
-
-
Sprenger, H.1
Lloyd, A.R.2
Meyer, R.G.3
Johnston, J.A.4
Kelvin, D.J.5
-
34
-
-
0028309557
-
Structure, genomic organization, and expression of the human interleukin-8 receptor B gene
-
Sprenger H, Lloyd AR, Lautens LL, Bonner TI, Kelvin DJ. Structure, genomic organization, and expression of the human interleukin-8 receptor B gene. J Biol Chem 1994, 269:11065-11072.
-
(1994)
J Biol Chem
, vol.269
, pp. 11065-11072
-
-
Sprenger, H.1
Lloyd, A.R.2
Lautens, L.L.3
Bonner, T.I.4
Kelvin, D.J.5
-
35
-
-
0026919657
-
Molecular evolution of the human interleukin-8 receptor gene cluster
-
10.1038/ng0992-31, 1303245
-
Ahuja SK, Ozcelik T, Milatovitch A, Francke U, Murphy PM. Molecular evolution of the human interleukin-8 receptor gene cluster. Nat Genet 1992, 2:31-36. 10.1038/ng0992-31, 1303245.
-
(1992)
Nat Genet
, vol.2
, pp. 31-36
-
-
Ahuja, S.K.1
Ozcelik, T.2
Milatovitch, A.3
Francke, U.4
Murphy, P.M.5
-
36
-
-
33947356279
-
G protein coupled receptor structure and activation
-
10.1016/j.bbamem.2006.10.021, 1876727, 17188232
-
Kobilka BK. G protein coupled receptor structure and activation. Biochim Biophys Acta 2007, 1768:794-807. 10.1016/j.bbamem.2006.10.021, 1876727, 17188232.
-
(2007)
Biochim Biophys Acta
, vol.1768
, pp. 794-807
-
-
Kobilka, B.K.1
-
37
-
-
9444267059
-
The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor
-
10.1074/jbc.271.34.20545, 8702798
-
Ahuja SK, Murphy PM. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996, 271:20545-20550. 10.1074/jbc.271.34.20545, 8702798.
-
(1996)
J Biol Chem
, vol.271
, pp. 20545-20550
-
-
Ahuja, S.K.1
Murphy, P.M.2
-
38
-
-
81355146334
-
Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy
-
10.1016/j.jmb.2011.08.025, 3236022, 22019593
-
Park SH, Casagrande F, Cho L, Albrecht L, Opella SJ. Interactions of interleukin-8 with the human chemokine receptor CXCR1 in phospholipid bilayers by NMR spectroscopy. J Mol Biol 2011, 414:194-203. 10.1016/j.jmb.2011.08.025, 3236022, 22019593.
-
(2011)
J Mol Biol
, vol.414
, pp. 194-203
-
-
Park, S.H.1
Casagrande, F.2
Cho, L.3
Albrecht, L.4
Opella, S.J.5
-
39
-
-
3142779910
-
Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain
-
10.1074/jbc.M313883200, 15133028
-
Rajagopalan L, Rajarathnam K. Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain. J Biol Chem 2004, 279:30000-30008. 10.1074/jbc.M313883200, 15133028.
-
(2004)
J Biol Chem
, vol.279
, pp. 30000-30008
-
-
Rajagopalan, L.1
Rajarathnam, K.2
-
40
-
-
0026333179
-
Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities
-
Clark-Lewis I, Schumacher C, Baggiolini M, Moser B. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 1991, 266:23128-23134.
-
(1991)
J Biol Chem
, vol.266
, pp. 23128-23134
-
-
Clark-Lewis, I.1
Schumacher, C.2
Baggiolini, M.3
Moser, B.4
-
41
-
-
0028305217
-
Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids
-
Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M. Structural requirements for interleukin-8 function identified by design of analogs and CXC chemokine hybrids. J Biol Chem 1994, 269:16075-16081.
-
(1994)
J Biol Chem
, vol.269
, pp. 16075-16081
-
-
Clark-Lewis, I.1
Dewald, B.2
Loetscher, M.3
Moser, B.4
Baggiolini, M.5
-
42
-
-
58149232586
-
The interleukin-8 pathway in cancer
-
10.1158/1078-0432.CCR-07-4843, 18980965
-
Waugh DJ, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741. 10.1158/1078-0432.CCR-07-4843, 18980965.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 6735-6741
-
-
Waugh, D.J.1
Wilson, C.2
-
43
-
-
70149115487
-
The functional significance behind expressing two IL-8 receptor types on PMN
-
10.1189/jlb.0208125, 19564575
-
Stillie R, Farooq SM, Gordon JR, Stadnyk AW. The functional significance behind expressing two IL-8 receptor types on PMN. J Leukoc Biol 2009, 86:529-543. 10.1189/jlb.0208125, 19564575.
-
(2009)
J Leukoc Biol
, vol.86
, pp. 529-543
-
-
Stillie, R.1
Farooq, S.M.2
Gordon, J.R.3
Stadnyk, A.W.4
-
44
-
-
0027279671
-
G protein-coupled signal transduction pathways for interleukin-8
-
10.1126/science.8316840, 8316840
-
Wu D, LaRosa GJ, Simon MI. G protein-coupled signal transduction pathways for interleukin-8. Science 1993, 261:101-103. 10.1126/science.8316840, 8316840.
-
(1993)
Science
, vol.261
, pp. 101-103
-
-
Wu, D.1
LaRosa, G.J.2
Simon, M.I.3
-
45
-
-
0030048490
-
Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils
-
10.1074/jbc.271.5.2832, 8576262
-
Knall C, Young S, Nick JA, Buhl AM, Worthen GS, Johnson GL. Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. J Biol Chem 1996, 271:2832-2838. 10.1074/jbc.271.5.2832, 8576262.
-
(1996)
J Biol Chem
, vol.271
, pp. 2832-2838
-
-
Knall, C.1
Young, S.2
Nick, J.A.3
Buhl, A.M.4
Worthen, G.S.5
Johnson, G.L.6
-
46
-
-
0030903025
-
Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases
-
10.1073/pnas.94.7.3052, 20320, 9096344
-
Knall C, Worthen GS, Johnson GL. Interleukin 8-stimulated phosphatidylinositol-3-kinase activity regulates the migration of human neutrophils independent of extracellular signal-regulated kinase and p38 mitogen-activated protein kinases. Proc Natl Acad Sci USA 1997, 94:3052-3057. 10.1073/pnas.94.7.3052, 20320, 9096344.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 3052-3057
-
-
Knall, C.1
Worthen, G.S.2
Johnson, G.L.3
-
47
-
-
32344445820
-
CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton-and integrinrelated mechanisms converge with FAK regulatory pathways in a receptor-specific manner
-
10.1016/j.cyto.2005.11.006, 16406804
-
Cohen-Hillel E, Yron I, Meshel T, Soria G, Attal H, Ben-Baruch A. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton-and integrinrelated mechanisms converge with FAK regulatory pathways in a receptor-specific manner. Cytokine 2006, 33:1-16. 10.1016/j.cyto.2005.11.006, 16406804.
-
(2006)
Cytokine
, vol.33
, pp. 1-16
-
-
Cohen-Hillel, E.1
Yron, I.2
Meshel, T.3
Soria, G.4
Attal, H.5
Ben-Baruch, A.6
-
49
-
-
84870825008
-
JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer
-
10.1016/j.ccr.2012.10.023, 23238015
-
Britschgi A, Andraos R, Brinkhaus H, Klebba I, Romanet V, Muller U, Murakami M, Radimerski T, Bentires-Alj M. JAK2/STAT5 inhibition circumvents resistance to PI3K/mTOR blockade: a rationale for cotargeting these pathways in metastatic breast cancer. Cancer Cell 2012, 22:796-811. 10.1016/j.ccr.2012.10.023, 23238015.
-
(2012)
Cancer Cell
, vol.22
, pp. 796-811
-
-
Britschgi, A.1
Andraos, R.2
Brinkhaus, H.3
Klebba, I.4
Romanet, V.5
Muller, U.6
Murakami, M.7
Radimerski, T.8
Bentires-Alj, M.9
-
50
-
-
46949098184
-
Interleukin-8 signaling promotes androgenindependent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
-
10.1093/carcin/bgn109, 18487223
-
Seaton A, Scullin P, Maxwell PJ, Wilson C, Pettigrew J, Gallagher R, O'Sullivan JM, Johnston PG, Waugh DJ. Interleukin-8 signaling promotes androgenindependent proliferation of prostate cancer cells via induction of androgen receptor expression and activation. Carcinogenesis 2008, 29:1148-1156. 10.1093/carcin/bgn109, 18487223.
-
(2008)
Carcinogenesis
, vol.29
, pp. 1148-1156
-
-
Seaton, A.1
Scullin, P.2
Maxwell, P.J.3
Wilson, C.4
Pettigrew, J.5
Gallagher, R.6
O'Sullivan, J.M.7
Johnston, P.G.8
Waugh, D.J.9
-
51
-
-
0032837477
-
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
-
10.1038/sj.bjc.6690742, 2362886, 10574250
-
Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, Yokozaki H, Yasui W, Mukaida N, Ohmoto Y, Kajiyama G, Fidler IJ, Tahara E. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999, 81:647-653. 10.1038/sj.bjc.6690742, 2362886, 10574250.
-
(1999)
Br J Cancer
, vol.81
, pp. 647-653
-
-
Kitadai, Y.1
Takahashi, Y.2
Haruma, K.3
Naka, K.4
Sumii, K.5
Yokozaki, H.6
Yasui, W.7
Mukaida, N.8
Ohmoto, Y.9
Kajiyama, G.10
Fidler, I.J.11
Tahara, E.12
-
52
-
-
65249183876
-
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis
-
10.1158/1078-0432.CCR-08-2387, 19293256
-
Singh S, Sadanandam A, Nannuru KC, Varney ML, Mayer-Ezell R, Bond R, Singh RK. Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis. Clin Cancer Res 2009, 15:2380-2386. 10.1158/1078-0432.CCR-08-2387, 19293256.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2380-2386
-
-
Singh, S.1
Sadanandam, A.2
Nannuru, K.C.3
Varney, M.L.4
Mayer-Ezell, R.5
Bond, R.6
Singh, R.K.7
-
53
-
-
11244328119
-
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
-
10.1038/sj.bjc.6602227, 2409768, 15545974
-
Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer 2004, 91:1970-1976. 10.1038/sj.bjc.6602227, 2409768, 15545974.
-
(2004)
Br J Cancer
, vol.91
, pp. 1970-1976
-
-
Zhu, Y.M.1
Webster, S.J.2
Flower, D.3
Woll, P.J.4
-
54
-
-
0031899883
-
Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue
-
Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. Anticancer Res 1998, 18:77-81.
-
(1998)
Anticancer Res
, vol.18
, pp. 77-81
-
-
Miller, L.J.1
Kurtzman, S.H.2
Wang, Y.3
Anderson, K.H.4
Lindquist, R.R.5
Kreutzer, D.L.6
-
55
-
-
0030820127
-
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours
-
10.1002/(SICI)1097-0215(19970917)72:6<937::AID-IJC3>3.0.CO;2-Q, 9378554
-
Green AR, Green VL, White MC, Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int J Cancer 1997, 72:937-941. 10.1002/(SICI)1097-0215(19970917)72:6<937::AID-IJC3>3.0.CO;2-Q, 9378554.
-
(1997)
Int J Cancer
, vol.72
, pp. 937-941
-
-
Green, A.R.1
Green, V.L.2
White, M.C.3
Speirs, V.4
-
56
-
-
33646379379
-
Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma
-
10.1016/j.humimm.2006.03.018, 16698420
-
Snoussi K, Mahfoudh W, Bouaouina N, Ahmed SB, Helal AN, Chouchane L. Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. Hum Immunol 2006, 67:13-21. 10.1016/j.humimm.2006.03.018, 16698420.
-
(2006)
Hum Immunol
, vol.67
, pp. 13-21
-
-
Snoussi, K.1
Mahfoudh, W.2
Bouaouina, N.3
Ahmed, S.B.4
Helal, A.N.5
Chouchane, L.6
-
57
-
-
77953307455
-
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness
-
10.1186/1471-2407-10-283, 2895614, 20540789
-
Snoussi K, Mahfoudh W, Bouaouina N, Fekih M, Khairi H, Helal A, Chouchane L. Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness. BMC Cancer 2010, 10:283. 10.1186/1471-2407-10-283, 2895614, 20540789.
-
(2010)
BMC Cancer
, vol.10
, pp. 283
-
-
Snoussi, K.1
Mahfoudh, W.2
Bouaouina, N.3
Fekih, M.4
Khairi, H.5
Helal, A.6
Chouchane, L.7
-
58
-
-
0035132152
-
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells
-
10.1016/S0002-9440(10)64005-9, 1850317, 11159200
-
De Larco JE, Wuertz BR, Rosner KA, Erickson SA, Gamache DE, Manivel JC, Furcht LT. A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol 2001, 158:639-646. 10.1016/S0002-9440(10)64005-9, 1850317, 11159200.
-
(2001)
Am J Pathol
, vol.158
, pp. 639-646
-
-
De Larco, J.E.1
Wuertz, B.R.2
Rosner, K.A.3
Erickson, S.A.4
Gamache, D.E.5
Manivel, J.C.6
Furcht, L.T.7
-
59
-
-
10444275091
-
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors
-
10.1016/j.canlet.2004.05.024, 15596298
-
Azenshtein E, Meshel T, Shina S, Barak N, Keydar I, Ben-Baruch A. The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Letters 2005, 217:73-86. 10.1016/j.canlet.2004.05.024, 15596298.
-
(2005)
Cancer Letters
, vol.217
, pp. 73-86
-
-
Azenshtein, E.1
Meshel, T.2
Shina, S.3
Barak, N.4
Keydar, I.5
Ben-Baruch, A.6
-
60
-
-
84865401715
-
Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population
-
10.1016/j.molcel.2012.06.014, 3432419, 22819326
-
Korkaya H, Kim GI, Davis A, Malik F, Henry NL, Ithimakin S, Quraishi AA, Tawakkol N, D'Angelo R, Paulson AK, Chung S, Luther T, Paholak HJ, Liu S, Hassan KA, Zen Q, Clouthier SG, Wicha MS. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol Cell 2012, 47:570-584. 10.1016/j.molcel.2012.06.014, 3432419, 22819326.
-
(2012)
Mol Cell
, vol.47
, pp. 570-584
-
-
Korkaya, H.1
Kim, G.I.2
Davis, A.3
Malik, F.4
Henry, N.L.5
Ithimakin, S.6
Quraishi, A.A.7
Tawakkol, N.8
D'Angelo, R.9
Paulson, A.K.10
Chung, S.11
Luther, T.12
Paholak, H.J.13
Liu, S.14
Hassan, K.A.15
Zen, Q.16
Clouthier, S.G.17
Wicha, M.S.18
-
61
-
-
84867635011
-
Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner
-
10.1158/1541-7786.MCR-12-0275, 3553584, 22893608
-
Bohrer LR, Schwertfeger KL. Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner. Mol Cancer Res 2012, 10:1294-1305. 10.1158/1541-7786.MCR-12-0275, 3553584, 22893608.
-
(2012)
Mol Cancer Res
, vol.10
, pp. 1294-1305
-
-
Bohrer, L.R.1
Schwertfeger, K.L.2
-
62
-
-
78751522709
-
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
-
10.1158/0008-5472.CAN-10-0538, 3100554, 21224357
-
Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011, 71:614-624. 10.1158/0008-5472.CAN-10-0538, 3100554, 21224357.
-
(2011)
Cancer Res
, vol.71
, pp. 614-624
-
-
Liu, S.1
Ginestier, C.2
Ou, S.J.3
Clouthier, S.G.4
Patel, S.H.5
Monville, F.6
Korkaya, H.7
Heath, A.8
Dutcher, J.9
Kleer, C.G.10
Jung, Y.11
Dontu, G.12
Taichman, R.13
Wicha, M.S.14
-
63
-
-
1542720301
-
Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays
-
10.1002/ijc.11724, 14991571
-
Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, Huang R-P. Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 2004, 109:507-515. 10.1002/ijc.11724, 14991571.
-
(2004)
Int J Cancer
, vol.109
, pp. 507-515
-
-
Lin, Y.1
Huang, R.2
Chen, L.3
Li, S.4
Shi, Q.5
Jordan, C.6
Huang, R.-P.7
-
64
-
-
34648822606
-
Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells
-
10.1002/ijc.22930, 17621625
-
Yao C, Lin Y, Chua M-S, Ye C-S, Bi J, Li W, Zhu Y-F, Wang S-M. Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer 2007, 121:1949-1957. 10.1002/ijc.22930, 17621625.
-
(2007)
Int J Cancer
, vol.121
, pp. 1949-1957
-
-
Yao, C.1
Lin, Y.2
Chua, M.-S.3
Ye, C.-S.4
Bi, J.5
Li, W.6
Zhu, Y.-F.7
Wang, S.-M.8
-
65
-
-
0036792257
-
Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo
-
Bendre MS, Gaddy-Kurten D, Mon-Foote T, Akel NS, Skinner RA, Nicholas RW, Suva LJ. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo. Cancer Res 2002, 62:5571-5579.
-
(2002)
Cancer Res
, vol.62
, pp. 5571-5579
-
-
Bendre, M.S.1
Gaddy-Kurten, D.2
Mon-Foote, T.3
Akel, N.S.4
Skinner, R.A.5
Nicholas, R.W.6
Suva, L.J.7
-
66
-
-
36148979810
-
CXC chemokines located in the 4q21 region are up-regulated in breast cancer
-
10.1677/erc.1.01301, 18045955
-
Bieche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, Guinebretiere J-M, Burlinchon S, Lidereau R, Lazennec G. CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocrine-Related Cancer 2007, 14:1039-1052. 10.1677/erc.1.01301, 18045955.
-
(2007)
Endocrine-Related Cancer
, vol.14
, pp. 1039-1052
-
-
Bieche, I.1
Chavey, C.2
Andrieu, C.3
Busson, M.4
Vacher, S.5
Le Corre, L.6
Guinebretiere, J.-M.7
Burlinchon, S.8
Lidereau, R.9
Lazennec, G.10
-
67
-
-
84864814631
-
Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis
-
3284109, 22368515
-
Nannuru KC, Sharma B, Varney ML, Singh RK. Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis. J Carcinog 2012, 10:40. 3284109, 22368515.
-
(2012)
J Carcinog
, vol.10
, pp. 40
-
-
Nannuru, K.C.1
Sharma, B.2
Varney, M.L.3
Singh, R.K.4
-
68
-
-
76649113726
-
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
-
10.1172/JCI39397, 2810075, 20051626
-
Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum D, Guan JL, Dontu G, Wicha MS. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 2010, 120:485-497. 10.1172/JCI39397, 2810075, 20051626.
-
(2010)
J Clin Invest
, vol.120
, pp. 485-497
-
-
Ginestier, C.1
Liu, S.2
Diebel, M.E.3
Korkaya, H.4
Luo, M.5
Brown, M.6
Wicinski, J.7
Cabaud, O.8
Charafe-Jauffret, E.9
Birnbaum, D.10
Guan, J.L.11
Dontu, G.12
Wicha, M.S.13
-
69
-
-
36248984827
-
Serum IL-8 and IL-12 levels in breast cancer
-
10.1007/BF02698035, 17848739
-
Derin D, Soydinc HO, Guney N, Tas F, Camlica H, Duranyildiz D, Yasasever V, Topuz E. Serum IL-8 and IL-12 levels in breast cancer. Med Oncol 2007, 24:163-168. 10.1007/BF02698035, 17848739.
-
(2007)
Med Oncol
, vol.24
, pp. 163-168
-
-
Derin, D.1
Soydinc, H.O.2
Guney, N.3
Tas, F.4
Camlica, H.5
Duranyildiz, D.6
Yasasever, V.7
Topuz, E.8
-
70
-
-
8444230395
-
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival
-
10.1158/1078-0432.CCR-04-0812, 15534087
-
Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpe S, Vermeulen PB, Dirix LY. Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clinical Cancer Res 2004, 10:7157-7162. 10.1158/1078-0432.CCR-04-0812, 15534087.
-
(2004)
Clinical Cancer Res
, vol.10
, pp. 7157-7162
-
-
Benoy, I.H.1
Salgado, R.2
Van Dam, P.3
Geboers, K.4
Van Marck, E.5
Scharpe, S.6
Vermeulen, P.B.7
Dirix, L.Y.8
-
71
-
-
84866534198
-
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
-
10.1007/s10549-012-2196-0, 22923236
-
Shi Z, Yang WM, Chen LP, Yang DH, Zhou Q, Zhu J, Chen JJ, Huang RC, Chen ZS, Huang RP. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Res Treat 2012, 135:737-747. 10.1007/s10549-012-2196-0, 22923236.
-
(2012)
Breast Cancer Res Treat
, vol.135
, pp. 737-747
-
-
Shi, Z.1
Yang, W.M.2
Chen, L.P.3
Yang, D.H.4
Zhou, Q.5
Zhu, J.6
Chen, J.J.7
Huang, R.C.8
Chen, Z.S.9
Huang, R.P.10
-
72
-
-
0035300589
-
Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents
-
De Larco JE, Wuertz BR, Manivel JC, Furcht LT. Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res 2001, 61:2857-2861.
-
(2001)
Cancer Res
, vol.61
, pp. 2857-2861
-
-
De Larco, J.E.1
Wuertz, B.R.2
Manivel, J.C.3
Furcht, L.T.4
-
73
-
-
60549111070
-
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature
-
10.1158/0008-5472.CAN-08-2741, 2819227, 19190339
-
Charafe-Jauff ret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, Hur MH, Diebel ME, Monville F, Dutcher J, Brown M, Viens P, Xerri L, Bertucci F, Stassi G, Dontu G, Birnbaum D, Wicha MS. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 2009, 69:1302-1313. 10.1158/0008-5472.CAN-08-2741, 2819227, 19190339.
-
(2009)
Cancer Res
, vol.69
, pp. 1302-1313
-
-
Charafe-Jauffret, E.1
Ginestier, C.2
Iovino, F.3
Wicinski, J.4
Cervera, N.5
Finetti, P.6
Hur, M.H.7
Diebel, M.E.8
Monville, F.9
Dutcher, J.10
Brown, M.11
Viens, P.12
Xerri, L.13
Bertucci, F.14
Stassi, G.15
Dontu, G.16
Birnbaum, D.17
Wicha, M.S.18
-
74
-
-
79960952144
-
IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells
-
3148346, 21653678
-
Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res 2012, 71:5296-5306. 3148346, 21653678.
-
(2012)
Cancer Res
, vol.71
, pp. 5296-5306
-
-
Fernando, R.I.1
Castillo, M.D.2
Litzinger, M.3
Hamilton, D.H.4
Palena, C.5
-
75
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
10.1016/j.cell.2008.03.027, 2728032, 18485877
-
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715. 10.1016/j.cell.2008.03.027, 2728032, 18485877.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
Campbell, L.L.11
Polyak, K.12
Brisken, C.13
Yang, J.14
Weinberg, R.A.15
-
76
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
10.1016/j.cell.2011.02.013, 21376230
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
-
(2011)
Cell
, vol.144
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
77
-
-
51449085561
-
Generation of breast cancer stem cells through epithelial-mesenchymal transition
-
10.1371/journal.pone.0002888, 2492808, 18682804
-
Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008, 3:e2888. 10.1371/journal.pone.0002888, 2492808, 18682804.
-
(2008)
PLoS One
, vol.3
-
-
Morel, A.P.1
Lievre, M.2
Thomas, C.3
Hinkal, G.4
Ansieau, S.5
Puisieux, A.6
-
78
-
-
84873333749
-
Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
-
10.1158/1078-0432.CCR-12-1063, 23149820
-
Singh JK, Farnie G, Bundred NJ, Simoes BM, Shergill A, Landberg G, Howell SJ, Clarke RB. Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms. Clin Cancer Res 2013, 19:643-656. 10.1158/1078-0432.CCR-12-1063, 23149820.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 643-656
-
-
Singh, J.K.1
Farnie, G.2
Bundred, N.J.3
Simoes, B.M.4
Shergill, A.5
Landberg, G.6
Howell, S.J.7
Clarke, R.B.8
-
79
-
-
84866307571
-
Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling
-
10.1158/2159-8290.CD-12-0101, 22763855
-
Li HJ, Reinhardt F, Herschman HR, Weinberg RA. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov 2012, 2:840-855. 10.1158/2159-8290.CD-12-0101, 22763855.
-
(2012)
Cancer Discov
, vol.2
, pp. 840-855
-
-
Li, H.J.1
Reinhardt, F.2
Herschman, H.R.3
Weinberg, R.A.4
-
80
-
-
84878552107
-
Growth of triplenegative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8
-
10.1158/0008-5472.CAN-12-4524-T, 23633491
-
Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck SG, Mills GB, Brown PH. Growth of triplenegative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer Res 2013, 73:3470-3480. 10.1158/0008-5472.CAN-12-4524-T, 23633491.
-
(2013)
Cancer Res
, vol.73
, pp. 3470-3480
-
-
Hartman, Z.C.1
Poage, G.M.2
den Hollander, P.3
Tsimelzon, A.4
Hill, J.5
Panupinthu, N.6
Zhang, Y.7
Mazumdar, A.8
Hilsenbeck, S.G.9
Mills, G.B.10
Brown, P.H.11
-
81
-
-
37049183697
-
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene
-
10.1126/science.3798106, 3798106
-
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/ neu oncogene. Science 1987, 235:177-182. 10.1126/science.3798106, 3798106.
-
(1987)
Science
, vol.235
, pp. 177-182
-
-
Slamon, D.J.1
Clark, G.M.2
Wong, S.G.3
Levin, W.J.4
Ullrich, A.5
McGuire, W.L.6
-
82
-
-
54049096261
-
HER2 regulates the mammary stem/ progenitor cell population driving tumorigenesis and invasion
-
10.1038/onc.2008.207, 2602947, 18591932
-
Korkaya H, Paulson A, Iovino F, Wicha MS. HER2 regulates the mammary stem/ progenitor cell population driving tumorigenesis and invasion. Oncogene 2008, 27:6120-6130. 10.1038/onc.2008.207, 2602947, 18591932.
-
(2008)
Oncogene
, vol.27
, pp. 6120-6130
-
-
Korkaya, H.1
Paulson, A.2
Iovino, F.3
Wicha, M.S.4
-
83
-
-
62549096930
-
Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab
-
10.1158/1078-0432.CCR-08-1327, 19276287
-
Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, Gasparini P, Sozzi G, Fontanella E, Menard S, Tagliabue E. Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin Cancer Res 2009, 15:2010-2021. 10.1158/1078-0432.CCR-08-1327, 19276287.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 2010-2021
-
-
Magnifico, A.1
Albano, L.2
Campaner, S.3
Delia, D.4
Castiglioni, F.5
Gasparini, P.6
Sozzi, G.7
Fontanella, E.8
Menard, S.9
Tagliabue, E.10
-
84
-
-
79959917275
-
HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis
-
10.1158/0008-5472.CAN-11-0308, 3129398, 21518778
-
Hartman ZC, Yang XY, Glass O, Lei G, Osada T, Dave SS, Morse MA, Clay TM, Lyerly HK. HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis. Cancer Res 2011, 71:4380-4391. 10.1158/0008-5472.CAN-11-0308, 3129398, 21518778.
-
(2011)
Cancer Res
, vol.71
, pp. 4380-4391
-
-
Hartman, Z.C.1
Yang, X.Y.2
Glass, O.3
Lei, G.4
Osada, T.5
Dave, S.S.6
Morse, M.A.7
Clay, T.M.8
Lyerly, H.K.9
-
85
-
-
33750584030
-
HER2 signaling modulates the equilibrium between pro-and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy
-
10.1038/sj.onc.1209685, 16715132
-
Wen XF, Yang G, Mao W, Thornton A, Liu J, Bast RC, Le XF. HER2 signaling modulates the equilibrium between pro-and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene 2006, 25:6986-6996. 10.1038/sj.onc.1209685, 16715132.
-
(2006)
Oncogene
, vol.25
, pp. 6986-6996
-
-
Wen, X.F.1
Yang, G.2
Mao, W.3
Thornton, A.4
Liu, J.5
Bast, R.C.6
Le, X.F.7
-
86
-
-
34247119113
-
Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer
-
10.1016/j.ejca.2007.01.037, 17379503
-
Vazquez-Martin A, Colomer R, Menendez JA. Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancer. Eur J Cancer 2007, 43:1117-1124. 10.1016/j.ejca.2007.01.037, 17379503.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1117-1124
-
-
Vazquez-Martin, A.1
Colomer, R.2
Menendez, J.A.3
-
87
-
-
84867297810
-
Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion
-
10.1186/bcr3329, 23062209
-
Aceto N, Duss S, Macdonald G, Meyer DS, Roloff TC, Hynes NE, Bentires-Alj M. Co-expression of HER2 and HER3 receptor tyrosine kinases enhances invasion of breast cells via stimulation of interleukin-8 autocrine secretion. Breast Cancer Res 2012, 14:R131. 10.1186/bcr3329, 23062209.
-
(2012)
Breast Cancer Res
, vol.14
-
-
Aceto, N.1
Duss, S.2
Macdonald, G.3
Meyer, D.S.4
Roloff, T.C.5
Hynes, N.E.6
Bentires-Alj, M.7
-
88
-
-
34248148710
-
Oestrogen receptor negative breast cancers exhibit high cytokine content
-
10.1186/bcr1648, 1851386, 17261184
-
Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D, Roques S, Lazennec G. Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 2007, 9:R15. 10.1186/bcr1648, 1851386, 17261184.
-
(2007)
Breast Cancer Res
, vol.9
-
-
Chavey, C.1
Bibeau, F.2
Gourgou-Bourgade, S.3
Burlinchon, S.4
Boissiere, F.5
Laune, D.6
Roques, S.7
Lazennec, G.8
-
89
-
-
67649969473
-
Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling
-
10.1371/journal.pbio.1000121, 2683567, 19492080
-
Korkaya H, Paulson A, Charafe-Jauff ret E, Ginestier C, Brown M, Dutcher J, Clouthier SG, Wicha MS. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol 2009, 7:e1000121. 10.1371/journal.pbio.1000121, 2683567, 19492080.
-
(2009)
PLoS Biol
, vol.7
-
-
Korkaya, H.1
Paulson, A.2
Charafe-Jauffret, E.3
Ginestier, C.4
Brown, M.5
Dutcher, J.6
Clouthier, S.G.7
Wicha, M.S.8
-
90
-
-
0030878456
-
Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45
-
175455, 9234778
-
Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K. Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 1997, 65:3218-3224. 175455, 9234778.
-
(1997)
Infect Immun
, vol.65
, pp. 3218-3224
-
-
Aihara, M.1
Tsuchimoto, D.2
Takizawa, H.3
Azuma, A.4
Wakebe, H.5
Ohmoto, Y.6
Imagawa, K.7
Kikuchi, M.8
Mukaida, N.9
Matsushima, K.10
-
91
-
-
0027379055
-
Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B
-
364780, 8413306
-
Stein B, Baldwin AS. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-kappa B. Mol Cell Biol 1993, 13:7191-7198. 364780, 8413306.
-
(1993)
Mol Cell Biol
, vol.13
, pp. 7191-7198
-
-
Stein, B.1
Baldwin, A.S.2
-
92
-
-
0042525815
-
Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB
-
Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, Yang XD, Gudas JM, McConkey DJ, Bar-Eli M. Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 2003, 9:3167-3175.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3167-3175
-
-
Mian, B.M.1
Dinney, C.P.2
Bermejo, C.E.3
Sweeney, P.4
Tellez, C.5
Yang, X.D.6
Gudas, J.M.7
McConkey, D.J.8
Bar-Eli, M.9
-
93
-
-
0036310021
-
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma
-
10.1016/S0002-9440(10)64164-8, 1850702, 12107097
-
Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, Gudas JM, Bar-Eli M. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol 2002, 161:125-134. 10.1016/S0002-9440(10)64164-8, 1850702, 12107097.
-
(2002)
Am J Pathol
, vol.161
, pp. 125-134
-
-
Huang, S.1
Mills, L.2
Mian, B.3
Tellez, C.4
McCarty, M.5
Yang, X.D.6
Gudas, J.M.7
Bar-Eli, M.8
-
94
-
-
47949101915
-
IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis
-
Skov L, Beurskens FJ, Zachariae CO, Reitamo S, Teeling J, Satijn D, Knudsen KM, Boot EP, Hudson D, Baadsgaard O, Parren PW, van de Winkel JG. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol 2008, 181:669-679.
-
(2008)
J Immunol
, vol.181
, pp. 669-679
-
-
Skov, L.1
Beurskens, F.J.2
Zachariae, C.O.3
Reitamo, S.4
Teeling, J.5
Satijn, D.6
Knudsen, K.M.7
Boot, E.P.8
Hudson, D.9
Baadsgaard, O.10
Parren, P.W.11
van de Winkel, J.G.12
-
95
-
-
84860249964
-
The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models
-
10.1158/1535-7163.MCT-11-0915, 22391039
-
Ning Y, Labonte MJ, Zhang W, Bohanes PO, Gerger A, Yang D, Benhaim L, Paez D, Rosenberg DO, Nagulapalli Venkata KC, Louie SG, Petasis NA, Ladner RD, Lenz HJ. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models. Mol Cancer Ther 2012, 11:1353-1364. 10.1158/1535-7163.MCT-11-0915, 22391039.
-
(2012)
Mol Cancer Ther
, vol.11
, pp. 1353-1364
-
-
Ning, Y.1
Labonte, M.J.2
Zhang, W.3
Bohanes, P.O.4
Gerger, A.5
Yang, D.6
Benhaim, L.7
Paez, D.8
Rosenberg, D.O.9
Nagulapalli Venkata, K.C.10
Louie, S.G.11
Petasis, N.A.12
Ladner, R.D.13
Lenz, H.J.14
-
96
-
-
78649630055
-
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
-
10.1016/j.canlet.2010.10.004, 2994987, 21035946
-
Varney ML, Singh S, Li A, Mayer-Ezell R, Bond R, Singh RK. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett 2011, 300:180-188. 10.1016/j.canlet.2010.10.004, 2994987, 21035946.
-
(2011)
Cancer Lett
, vol.300
, pp. 180-188
-
-
Varney, M.L.1
Singh, S.2
Li, A.3
Mayer-Ezell, R.4
Bond, R.5
Singh, R.K.6
-
97
-
-
0029103127
-
Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration
-
10.1038/bjc.1995.398, 2033873, 7669585
-
Hirose K, Hakozaki M, Nyunoya Y, Kobayashi Y, Matsushita K, Takenouchi T, Mikata A, Mukaida N, Matsushima K. Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br J Cancer 1995, 72:708-714. 10.1038/bjc.1995.398, 2033873, 7669585.
-
(1995)
Br J Cancer
, vol.72
, pp. 708-714
-
-
Hirose, K.1
Hakozaki, M.2
Nyunoya, Y.3
Kobayashi, Y.4
Matsushita, K.5
Takenouchi, T.6
Mikata, A.7
Mukaida, N.8
Matsushima, K.9
-
98
-
-
53549123079
-
Immune-mediated dormancy: an equilibrium with cancer
-
10.1189/jlb.1107774, 18515327
-
Teng MW, Swann JB, Koebel CM, Schreiber RD, Smyth MJ. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol 2008, 84:988-993. 10.1189/jlb.1107774, 18515327.
-
(2008)
J Leukoc Biol
, vol.84
, pp. 988-993
-
-
Teng, M.W.1
Swann, J.B.2
Koebel, C.M.3
Schreiber, R.D.4
Smyth, M.J.5
-
99
-
-
84862519263
-
Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial
-
10.1111/j.1365-2222.2012.04014.x, 22702508
-
Nair P, Gaga M, Zervas E, Alagha K, Hargreave FE, O'Byrne PM, Stryszak P, Gann L, Sadeh J, Chanez P. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy 2012, 42:1097-1103. 10.1111/j.1365-2222.2012.04014.x, 22702508.
-
(2012)
Clin Exp Allergy
, vol.42
, pp. 1097-1103
-
-
Nair, P.1
Gaga, M.2
Zervas, E.3
Alagha, K.4
Hargreave, F.E.5
O'Byrne, P.M.6
Stryszak, P.7
Gann, L.8
Sadeh, J.9
Chanez, P.10
-
100
-
-
4143050328
-
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury
-
10.1073/pnas.0402090101, 511013, 15282370
-
Bertini R, Allegretti M, Bizzarri C, Moriconi A, Locati M, Zampella G, Cervellera MN, Di Cioccio V, Cesta MC, Galliera E, Martinez FO, Di Bitondo R, Troiani G, Sabbatini V, D'Anniballe G, Anacardio R, Cutrin JC, Cavalieri B, Mainiero F, Strippoli R, Villa P, Di Girolamo M, Martin F, Gentile M, Santoni A, Corda D, Poli G, Mantovani A, Ghezzi P, Colotta F. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci USA 2004, 101:11791-11796. 10.1073/pnas.0402090101, 511013, 15282370.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 11791-11796
-
-
Bertini, R.1
Allegretti, M.2
Bizzarri, C.3
Moriconi, A.4
Locati, M.5
Zampella, G.6
Cervellera, M.N.7
Di Cioccio, V.8
Cesta, M.C.9
Galliera, E.10
Martinez, F.O.11
Di Bitondo, R.12
Troiani, G.13
Sabbatini, V.14
D'Anniballe, G.15
Anacardio, R.16
Cutrin, J.C.17
Cavalieri, B.18
Mainiero, F.19
Strippoli, R.20
Villa, P.21
Di Girolamo, M.22
Martin, F.23
Gentile, M.24
Santoni, A.25
Corda, D.26
Poli, G.27
Mantovani, A.28
Ghezzi, P.29
Colotta, F.30
more..
-
101
-
-
33947717211
-
Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia
-
Leitner JM, Mayr FB, Firbas C, Spiel AO, Steinlechner B, Novellini R, Jilma B. Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia. Int J Immunopathol Pharmacol 2007, 20:25-36.
-
(2007)
Int J Immunopathol Pharmacol
, vol.20
, pp. 25-36
-
-
Leitner, J.M.1
Mayr, F.B.2
Firbas, C.3
Spiel, A.O.4
Steinlechner, B.5
Novellini, R.6
Jilma, B.7
-
102
-
-
80053401068
-
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
-
10.1172/JCI57099, 3223613, 21965337
-
Korkaya H, Liu S, Wicha MS. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J Clin Invest 2011, 121:3804-3809. 10.1172/JCI57099, 3223613, 21965337.
-
(2011)
J Clin Invest
, vol.121
, pp. 3804-3809
-
-
Korkaya, H.1
Liu, S.2
Wicha, M.S.3
-
103
-
-
84873391501
-
Breast cancer stem cells: we've got them surrounded
-
10.1158/1078-0432.CCR-12-3450, 23251003
-
Korkaya H, Wicha MS. Breast cancer stem cells: we've got them surrounded. Clin Cancer Res 2013, 19:511-513. 10.1158/1078-0432.CCR-12-3450, 23251003.
-
(2013)
Clin Cancer Res
, vol.19
, pp. 511-513
-
-
Korkaya, H.1
Wicha, M.S.2
-
104
-
-
84884208200
-
Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC) [Abstract]
-
Schott A, Wicha M, Cristofanilli M, Ruffini P, McCanna S, Reuben J, Goldstein L. Phase Ib pilot study to evaluate reparixin in combination with chemotherapy with weekly paclitaxel in patients with HER-2 negative metastatic breast cancer (MBC) [Abstract]. Cancer Res 2012, 72(24 Suppl):571s.
-
(2012)
Cancer Res
, vol.72
, Issue.24 SUPPL
-
-
Schott, A.1
Wicha, M.2
Cristofanilli, M.3
Ruffini, P.4
McCanna, S.5
Reuben, J.6
Goldstein, L.7
|